HAMILTON, Ontario, Aug. 22, 2017 -- Hamilton-based Marquee Health Group Limited announced today that long-time Canadian retail industry leader Grant Froese is joining the company as Chief Executive Officer. In his new role, Froese will have responsibility for all operations, marketing and financial reporting for the company in the emerging regulated cannabis therapy industry.
Froese is joining Marquee Health following a 38-year career at Canadian retail giant Loblaw Companies Limited. Froese has led all levels of operations and merchandising and has had oversight of information technology, supply chain, digital/e-commerce businesses, marketing, and Loblaw’s industry-leading control brands.
“Grant’s leadership experience and ability to manage a complex business in an evolving operating environment is a significant benefit to Marquee Health and our growth,” says Marquee’s Co-Founder Paul Bernier. “Our future success is based on our ability to ensure a superior end-to-end experience for the consumer, an efficient and scalable supply chain and a supportive industry that is relentlessly focused on safety and quality. He is a great addition to our team, not to mention the credibility his appointment brings to the industry.”
Under Froese’s leadership, and with its vision and infrastructure, Marquee Health Group is in the final regulatory stages of becoming Canada’s preferred provider of cannabis for medical and, prospectively, adult recreational use. The company believes everyone should have the opportunity to live their best life and exists to offer hope and optimism for people seeking therapeutic options they can trust. Marquee Health is committed to innovation and quality control from the seeds it plants to the products it produces.
“Leading Marquee and helping people live their best lives is an opportunity I just couldn’t pass up,” said Froese. “I believe quite strongly that with our people, vision and products we can make a difference to thousands of Canadians and at the same time drive shareholder value. I’m looking forward to working with the team and industry stakeholders to ensure we meet and exceed the needs of consumers in a safe and consistent way.”
Marquee Health’s phase one, 20,000-square-foot growing facility is currently being constructed in Flamborough, Ontario. Future plans for the facility include a 40,000-square-foot expansion.
About Marquee Health Group Limited:
Marquee Health Group Limited, and its wholly owned subsidiary Pharm Meds Limited, is in the late stages of the regulatory approval process to offer regulated cannabis therapies that help people feel and live better. Marquee Health’s goal is to provide patients with access to safe, reliable, and high quality pharmaceutical cannabis and cannabis derivatives, in compliance with the Access to Cannabis for Medical Purposes Regulation (ACMPR). For more information visit www.marqueehealth.co.
Media Contact: Alycia Walker Republic – Account Coordinator [email protected] O: (416) 537-4444 x.1008 M: (416) 565-9183


Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Shell M&A Chief Exits After BP Takeover Proposal Rejected
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



